Journey Medical reports Emrosi sales up 84% in third quarter of 2026Nov 12Quarterly updateFortress Biotech, Inc.Journey Medical Corp
CorMedix to acquire Heron Therapeutics assets, reports Q3 2026 resultsNov 12Quarterly updateCorMedix Inc.
Pfizer registers real-world observational study of marstacimab in hemophilia A and B patientsOct 9Weekly roundup, 8 itemsabrocitinibcyclophosphamide